$KLAC

WALLACE RICHARD P sold $17.4M of KLAC

WALLACE RICHARD P (President and CEO) sold 87,568 shares of KLA CORP (KLAC) at $198.95 ($17.42M total) on 2026-08-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WALLACE RICHARD P
Published Aug 12, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KLAC
Neutral
medium confidence
Mentioned
$KLAC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KLACNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around management confidence, but the pre-arranged nature typically makes it less actionable than unscheduled selling or other fundamental disclosures.

02

Market read

A CEO sold about $17.42M of KLAC stock at a stated price, disclosed via Form 4 with a 10b5-1 plan.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-scheduled plans; without changes in guidance or operating news, the trading edge is limited.

Relevance 6/10Novelty 4/10Timing: filed after-hours on 2026-08-12, covering a sale dated 2026-08-11

Background

The article is a SEC Form 4 insider transaction disclosure for KLA Corp, listing the CEO’s role and a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$KLACNeutralMedium confidence
Context

KLA insider Wallace Richard P sold 87,568 shares at $198.95 each for about $17.42M under a pre-arranged 10b5-1 plan.

Expected impact

Near-term impact likely limited; any reaction should fade unless accompanied by other company-specific news.

Evidence & confidence

The filing is a primary Form 4 disclosure with transaction size and price, but it is explicitly tied to a pre-arranged 10b5-1 plan, which typically limits interpretive value for near-term fundamentals.

Market effects

No direct sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity planning under a 10b5-1 plan, so it should not be treated as a bearish fundamental signal.

Key entities

  • KLA Corp

    Subject of the Form 4 insider sale disclosure.

  • Wallace Richard P

    President and CEO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMATMed

Applied Materials is Down 6% Premarket. Will It Drag Down Lam Research, KLA, and Other Semi Equipment Stocks?

Applied Materials (AMAT) fell about 5.7% premarket after record fiscal Q3 results but guidance for Q4 revenue and margins missed elevated expectations. The company reported record Q3 revenue of $9.1B and non-GAAP EPS of $3.50, and guided Q4 revenue to $10.25B plus or minus $500M and EPS to $4.02 plus or minus $0.20. Lam Research (LRCX) and KLA (KLAC) were little changed premarket.

$AMATMed

Bernstein raises WFE growth estimates, boosts price targets

Bernstein raised its wafer fabrication equipment (WFE) spending forecasts, citing confidence the semiconductor upcycle will continue. It lifted 2026 WFE to $148B (+26.3% YoY), 2027 to $204B (+32.6%), and 2028 to $259B (+27%). Price targets were increased for Lam Research, KLA, and Applied Materials, plus preferences for Tokyo Electron, Kokusai, and ASML.

$PLTRMedAI 8/10

Dow and S&P 500 Hit Record Highs as Palantir Soars 20%, Caterpillar Jumps 10% on Earnings Beat; Oil Plunges 5% on US

US stocks extended gains to three sessions, with the Dow and S&P 500 hitting record highs. Palantir (PLTR) rose about 20% after Q2 results: revenue $1.94B (+93% YoY) and adjusted EPS $0.41 vs $0.35; full-year 2026 revenue outlook raised to $8.150B-$8.158B. Caterpillar (CAT) jumped about 10.5% on Q2 beat and $20.54B revenue. Oil fell ~5% on US-Iran deal hopes.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.